These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28651018)

  • 1. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
    Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
    Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.
    Xu W; Liu S; Ma L; Cheng L; Li Q; Qing L; Yang Y; Dong Z
    Comput Biol Med; 2024 Sep; 180():108989. PubMed ID: 39142223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-196a-mediated downregulation of p27
    Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
    Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
    Zhao Z; Stephan C; Weickmann S; Jung M; Kristiansen G; Jung K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
    Kumar B; Rosenberg AZ; Choi SM; Fox-Talbot K; De Marzo AM; Nonn L; Brennen WN; Marchionni L; Halushka MK; Lupold SE
    Sci Rep; 2018 May; 8(1):7189. PubMed ID: 29739972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.
    Karatas OF; Guzel E; Suer I; Ekici ID; Caskurlu T; Creighton CJ; Ittmann M; Ozen M
    PLoS One; 2014; 9(6):e98675. PubMed ID: 24967583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse.
    Konoshenko MY; Laktionov PP
    Andrology; 2021 Jul; 9(4):1092-1107. PubMed ID: 33638886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A; Mikula M; Dabrowska M; Kulecka M; Goryca K; Antoniewicz A; Dobruch J; Borowka A; Rutkowski P; Ostrowski J
    Prostate; 2018 Feb; 78(3):178-185. PubMed ID: 29226351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients.
    Schmidt L; Fredsøe J; Kristensen H; Strand SH; Rasmussen A; Høyer S; Borre M; Mouritzen P; Ørntoft T; Sørensen KD
    Ann Oncol; 2018 Sep; 29(9):2003-2009. PubMed ID: 30010760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1, a Potential Predictive Biomarker for Recurrence in Prostate Cancer After Radical Prostatectomy.
    Wei W; Leng J; Shao H; Wang W
    Am J Med Sci; 2017 Apr; 353(4):315-319. PubMed ID: 28317618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy.
    Mortensen MM; Høyer S; Orntoft TF; Sørensen KD; Dyrskjøt L; Borre M
    BMC Cancer; 2014 Nov; 14():859. PubMed ID: 25416653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.
    Zheng Q; Peskoe SB; Ribas J; Rafiqi F; Kudrolli T; Meeker AK; De Marzo AM; Platz EA; Lupold SE
    Prostate; 2014 Dec; 74(16):1655-62. PubMed ID: 25252191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.